Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells

Mikio Tomida1, Hideki Ohtake, Takashi Yokota

  • 1Research Institute for Clinical Oncology, Saitama Cancer Center, 818 Komuro, Ina, Saitama 362-0806, Japan. tomida@cancer-c.pref.saitama.jp.

Abstract

Insights

Nicotinamide N-methyltransferase (NNMT) is a novel gene regulated by signal transducers and activators of transcription 3 (Stat3). NNMT expression correlates with Stat3 activation in colon cancer, suggesting its potential as a tumor marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Constitutive activation of signal transducers and activators of transcription 3 (Stat3) is implicated in numerous human cancers.
  • Identifying Stat3-regulated genes is crucial for discovering novel cancer therapeutic and diagnostic targets.

Purpose of the Study:

  • To identify novel molecular targets for cancer therapy and diagnosis by surveying Stat3-regulated genes.
  • To investigate the role of Nicotinamide N-methyltransferase (NNMT) as a potential Stat3-regulated gene in various cancers.

Main Methods:

  • Utilized cDNA microarray analysis to identify Stat3-induced genes in 293 cells.
  • Examined NNMT expression in cancer cell lines using real-time quantitative RT-PCR.
  • Assessed NNMT promoter activity in response to Stat3 activation in Hep-G2 cells.
  • Performed immunohistochemical analysis of NNMT and activated Stat3 in colon cancer tissues.

Main Results:

  • Nicotinamide N-methyltransferase (NNMT) was identified as a Stat3-induced gene.
  • NNMT expression and promoter activity were found to be dependent on Stat3 activation in cancer cells.
  • A significant correlation between NNMT expression and activated Stat3 was observed in colon cancer tissues.
  • NNMT levels decreased upon inhibition of Stat3 phosphorylation.

Conclusions:

  • Nicotinamide N-methyltransferase (NNMT) is a newly identified Stat3-regulated gene.
  • Elevated NNMT expression is associated with Stat3 activation in colon cancer.
  • NNMT represents a potential candidate biomarker for various cancer types.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...